Amdocs Ebitda from 2010 to 2026

AOS Stock  EUR 61.20  0.22  0.36%   
Amdocs' EBITDA is increasing over the last several years with slightly volatile swings. EBITDA is predicted to flatten to about 850.9 M. During the period from 2010 to 2026 Amdocs Limited EBITDA regressed destribution of quarterly values had coefficient of variationof  12.48 and r-value of  0.80. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
B
Current Value
850.9 M
Quarterly Volatility
99.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Amdocs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amdocs' main balance sheet or income statement drivers, such as Interest Expense of 51.2 M, Selling General Administrative of 542.7 M or Total Revenue of 4.6 B, as well as many indicators such as . Amdocs financial statements analysis is a perfect complement when working with Amdocs Valuation or Volatility modules.
  
This module can also supplement various Amdocs Technical models . Check out the analysis of Amdocs Correlation against competitors.
For more detail on how to invest in Amdocs Stock please use our How to Invest in Amdocs guide.
The Ebitda trend for Amdocs Limited offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Amdocs is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Amdocs' Ebitda Growth Pattern

Below is the plot of the Ebitda of Amdocs Limited over the last few years. It is Amdocs' EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amdocs' overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Amdocs Ebitda Regression Statistics

Arithmetic Mean800,062,477
Geometric Mean794,413,030
Coefficient Of Variation12.48
Mean Deviation81,128,091
Median777,570,000
Standard Deviation99,841,270
Sample Variance9968.3T
Range398.7M
R-Value0.80
Mean Square Error3776T
R-Squared0.64
Significance0.0001
Slope15,877,267
Total Sum of Squares159492.5T

Amdocs Ebitda History

2026850.9 M
2025B
2021899.3 M
2020807.5 M
2019792.2 M
2018777.6 M
2017635.5 M

About Amdocs Financial Statements

Amdocs stakeholders use historical fundamental indicators, such as Amdocs' Ebitda, to determine how well the company is positioned to perform in the future. Although Amdocs investors may analyze each financial statement separately, they are all interrelated. For example, changes in Amdocs' assets and liabilities are reflected in the revenues and expenses on Amdocs' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Amdocs Limited. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDAB850.9 M

Currently Active Assets on Macroaxis

Other Information on Investing in Amdocs Stock

Amdocs financial ratios help investors to determine whether Amdocs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amdocs with respect to the benefits of owning Amdocs security.